Semaphorin 3F Antibody [DyLight 350]
Novus Biologicals, part of Bio-Techne | Catalog # AF3237D

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse
Applications
Western Blot
Label
DyLight 350 (Excitation = 353 nm, Emission = 432 nm)
Antibody Source
Polyclonal Sheep IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse Semaphorin 3F
Ala19-Pro775 (Arg583Ala, Arg586Ala)
Accession # O88632
Ala19-Pro775 (Arg583Ala, Arg586Ala)
Accession # O88632
Specificity
Detects human and mouse Semaphorin 3F in direct ELISAs and Western blots. In direct ELISAs, less than 1% cross-reactivity with recombinant mouse (rm) Semaphorin 3B and rmSemaphorin 3C is observed.
Clonality
Polyclonal
Host
Sheep
Isotype
IgG
Applications for Semaphorin 3F Antibody [DyLight 350]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Semaphorin 3F
Alternate Names
Sema3F, SEMA4, SEMAK
Gene Symbol
SEMA3F
Additional Semaphorin 3F Products
Product Documents for Semaphorin 3F Antibody [DyLight 350]
Product Specific Notices for Semaphorin 3F Antibody [DyLight 350]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...